Citi Pharma and CCL Pharma execute agreement to manufacture Formulation Products

MG News | July 14, 2021 at 03:22 PM GMT+05:00

0:00

July 14, 2021 (MLN): Citi Pharma Limited (CPHL) and CCL Pharma (Pvt) Limited have executed an agreement to manufacture Formulation Products on their behalf

In a notification to PSX, CPHL informed that this will lead to enhance capacity utilization on the Company’s Formulation segment. Furthermore, this will lead to the addition in Company’s profitability and net margins over the next 2 to 3 years.

Copyright Mettis Link News

Related News

PSX Closing Bell: From Boom to Breather

SHC grants interim relief to K-Electric in NEPRA case

NETSOL partners with NAVTTC to train 1,600 Professionals in AI, Data Science

Name	Price/Vol	%Chg/NChg
KSE100	159,578.19 333.05M	-1.06% -1703.58
ALLSHR	96,931.71 859.27M	-1.06% -1038.66
KSE30	48,368.92 143.32M	-1.28% -626.04
KMI30	228,555.67 91.55M	-1.25% -2892.46
KMIALLSHR	63,191.08 415.18M	-1.09% -697.97
BKTi	44,527.46 36.31M	-1.13% -510.27
OGTi	30,789.14 8.49M	-0.76% -236.44

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	101,935.00	102,705.00 99,285.00	905.00 0.90%
BRENT CRUDE	64.90	64.95 63.90	0.46 0.71%
RICHARDS BAY COAL MONTHLY	87.00	87.00 87.00	0.20 0.23%
ROTTERDAM COAL MONTHLY	97.50	97.50 97.50	-0.25 -0.26%
USD RBD PALM OLEIN	1,082.50	1,082.50 1,082.50	0.00 0.00%
CRUDE OIL - WTI	61.03	61.09 60.01	0.47 0.78%
SUGAR #11 WORLD	14.14	14.25 14.05	-0.08 -0.56%